Avacta Group PLC
LSE:AVCT
Avacta Group PLC
Gross Profit
Avacta Group PLC
Gross Profit Peer Comparison
Competitive Gross Profit Analysis
Latest Figures & CAGR of Competitors
Company | Gross Profit | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Avacta Group PLC
LSE:AVCT
|
Gross Profit
£8.7m
|
CAGR 3-Years
61%
|
CAGR 5-Years
36%
|
CAGR 10-Years
19%
|
|
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
|
Gross Profit
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Autolus Therapeutics PLC
NASDAQ:AUTL
|
Gross Profit
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Bicycle Therapeutics PLC
NASDAQ:BCYC
|
Gross Profit
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Immunocore Holdings PLC
NASDAQ:IMCR
|
Gross Profit
£248.4m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Genus PLC
LSE:GNS
|
Gross Profit
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Avacta Group PLC's Gross Profit?
Gross Profit
8.7m
GBP
Based on the financial report for Jun 30, 2023, Avacta Group PLC's Gross Profit amounts to 8.7m GBP.
What is Avacta Group PLC's Gross Profit growth rate?
Gross Profit CAGR 10Y
19%
Over the last year, the Gross Profit growth was 140%. The average annual Gross Profit growth rates for Avacta Group PLC have been 61% over the past three years , 36% over the past five years , and 19% over the past ten years .